Here are relevant reports on : human-resources-hiring-market
-
Cell Viability Assays Market by Product (MTT Assay, XTT Assay, Calcein, Resazurin, Flow Cytometry, Spectrophotometer), Cell Type (Human, Animal, Microbial), Application (Basic Research, Stem Cell, Discovery & Development) - Global Forecast to 2023
The global cell viability assays market is projected to reach USD 4.16 billion by 2023, growing at a CAGR of 8.4%. The prominent players in the cell viability assays market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck (Germany), GE Healthcare (US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), G-Biosciences (US), Creative Bioarray (US), Danaher Corporation (US), and Becton, Dickinson and Company (US).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
Probiotics Market Report by Product Type (Functional Food & Beverages (FnB), Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel, and Region - Global Forecast to 2030
The global probiotics market is estimated to be valued at USD 76.59 billion in 2025 and is projected to reach USD 114.95 billion by 2030, growing at a CAGR of 8.5% from 2025 to 2030. Key players in this market include Probi (Sweden), Nestlé (Switzerland), ADM (US), Danone (France), International Flavors & Fragrances Inc. (US), Yakult Honsha Co., Ltd. (Japan), BioGaia (Sweden), MORINAGA MILK INDUSTRY CO., LTD. (Japan), Meiji Holdings Co., Ltd. (Japan), Lifeway Foods, Inc. (US), Adisseo (France), Winclove Probiotics (US), AB-Biotics, S.A. (Belgium), Apsen Farmacêutica (Brazil), and Lallemand (Canada).
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Nutrigenomics Market: A boon to Human Health, Perspective by Applications and Geography - Global Trends and Forecasts up to 2017
As a result of globalization, the global population is being more health conscious. The ever increasing middleclass families also prefer the healthy diet and are more concerned towards nutrition. Thus the pioneering concept of Nutrigenomics has been boon for human health which provides a customized food which helps in optimum utilization of nutrients.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Human Microbiome Market by Drug & Supplement (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Diseases), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
The Asia Pacific Human Microbiome Market, valued at US$0.19 billion in 2024, stood at US$0.26 billion in 2025 and is projected to advance at a resilient CAGR of 31.0% from 2025 to 2031, culminating in a forecasted valuation of US$1.31 billion by the end of the period. Market growth is driven by an increasing focus on preventive and personalized health, rising adoption of microbiome-based diagnostics and therapeutic solutions, and rapid advances in next-generation sequencing, AI-enabled microbiome analytics, and regional bioinformatics capabilities.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Europe Probiotics Market by Product Type (Functional Food & Beverages, Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel, and Region - Forecast to 2030
The Europe probiotics market is estimated to be USD 15.73 billion in 2025 and is projected to reach USD 20.56 billion by 2030, registering at a CAGR of 5.5% from 2025 to 2030. The key players such as Danone S.A. (France), Probi AB (Sweden), Nestlé S.A. (Switzerland), Kerry Group plc (Ireland), BioGaia AB (Sweden), Bio-K Plus International Inc. (Canada), Daflorn Probiotics Ltd. (Bulgaria), Yakult Honsha Co., Ltd. (Japan), Arla Foods (Denmark), and AB-Biotics S.A. (Spain).
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Process Orchestration Market by Component, Business Function (Supply Chain Management and Order Fulfillment, Marketing, and Human Resource Management), Deployment Type, Organization Size, Industry Vertical, and Region - Global Forecast to 2023
The process orchestration market is expected to grow from USD 3.79 billion in 2018 to USD 8.50 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 17.5% during the forecast period. Several factors that are expected to drive the process orchestration market include the integration of Artificial Intelligence (AI) and Machin Learning (ML) technologies with the process orchestration solution, demand for IT resources according to business priorities, and improved IT systems to meet customers’ dynamic requirements. Industry verticals such as Banking, Financial Services, and Insurance (BFSI), and consumer goods and retail are expected to have significantly contributed to the growth of the process orchestration market. Major vendors who offer process orchestration solution and services across the globe include SAP (Germany), IBM (US), Oracle (US), CA Technologies (US), ServiceNow (US), Cisco (US), BMC Software (US), Fujitsu (Japan), OpenText (Canada), TIBCO (US), Software AG (Germany), HCL (India), Wipro (India), Newgen Software (India),Everteam (France), Arvato (Germany), Ayehu (US), Micro Focus (UK), Icaro Tech (Brazil), Cortex (UK), eQ Technologic (US), PMG (US), Nipendo (US), Dealflo (UK), and Data Ductus (Sweden).
- Published: June 2018
- Price: $ 4950
- TOC Available:
-
Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics, Synbiotics, Diagnostics), Disease (Infectious, Gastrointestinal), Route (Oral, Rectal), CDMO (Formulation, Strain Engineering), Type (BCT/FMT, Live Bacteria) - Global Forecast to 2031
The global human microbiome market, valued at USD 0.91 billion in 2024, stood at USD 1.40 billion in 2025 and is projected to advance at a resilient CAGR of 31.0% from 2025 to 2031, culminating in a forecasted valuation of USD 7.09 billion by the end of the period. North American market held the largest share during the forecast period due to the rising investments by governments and industries, and presence of a strong human microbiome ecosystem supporting innovation in this field.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
North America Human Microbiome Market By Drug & Supplement (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Diseases), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
North America Human Microbiome market, valued at US$0.43 billion in 2024, stood at US$0.78 billion in 2025 and is projected to advance at a resilient CAGR of 32.2% from 2025 to 2031, culminating in a forecasted valuation of US$4.15 billion by the end of the period. New startups in the US and Canada are driving innovation across microbiome therapeutics and diagnostics.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Power SCADA Market by Architecture (Hardware, Software, Services), Component (Remote Terminal Unit, Programmable Logic Controller, Human Machine Interface, Communication Systems, Protection relays, MTU), End User and Region - Global Forecast to 2028
The power SCADA market is projected to reach USD 2.9 billion by 2028, a notable compound annual growth rate (CAGR) of 7.1% during the forecast period. Key players in the global power SCADA market include ABB (Switzerland), Rockwell Automation (US), Siemens (Germany), Schneider Electric (France), and Emerson (US).
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Human Microbiome Manufacturing Services Market by Type (Fermentation & Downstream Processing, Strain Development & Optimization), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Disease) - Global Forecast to 2031
The global Human Microbiome Manufacturing Services market, valued at US$0.09 billion in 2024, stood at US$0.11 billion in 2025 and is projected to advance at a resilient CAGR of 16.7% from 2025 to 2031, culminating in a forecasted valuation of US$0.27 billion by the end of the period. Growing demand for specialized capabilities, such as anaerobic fermentation, microbial process scale-up, formulation, and fill-finish, is fueling broader adoption of human microbiome manufacturing services.
- Published: August 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
